ada standards of care 2025 obesity pharmacotherapy glp-1 Nutritional priorities to support therapy for obesity: A joint advisory from the American College Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and the Obesity Society Diabetes Standards of Care (2025)

Persistent or severe constipation should never be ignored, especially when taking medications like GLP-1 agonists

Nevertheless, rifaximin has shown earlier improvement and fewer side effects.23,25,27 Likewise, the use of oral vancomycin was reported to reduce the diversity of the gut microbiota.28 In a Japanese study on 12 patients with lactulose-resistant HE, vancomycin was added to the management and the HE grade improved.29 The results of that small blind study suggest that vancomycin could be an option in patients that do not respond to treatment with lactulose, but that should be cautiously interpreted, given the design of that study and the fact that there is scant evidence on the use of said drug

Today, fusion is no longer defined solely by hardware

These plans dont necessarily have a specific end date, which may be useful for ongoing treatment

10.1038/nature09410 Nature 91 LeeJ